日本糖尿病市場規模、シェア、競争環境、トレンド分析レポート : 治療タイプ別（経口抗糖尿病薬、インスリン）動向分析レポート： 2025年～2033年の世界機会分析と産業予測

レポートID : ROJP0524053 | 最終更新 : 2025年06月 | フォーマット : : :

Save

無料サンプル

試読申込

見積もり

1 Preface
2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary
4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Diabetes Disease Overview
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications

6 Japan Diabetes Epidemiology

6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group

7 Japan Diabetes Market

7.1 Market Overview
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
7.5.1 Overview
7.6.2 Strengths
7.7.3 Weaknesses
7.8.4 Opportunities
7.9.5 Threats
7.10 Value Chain Analysis
7.7 Porter’s Five Forces Analysis
7.7.1 Overview
7.7.2 Bargaining Power of Buyers
7.7.3 Bargaining Power of Suppliers
7.7.4 Degree of Competition
7.7.5 Threat of New Entrants
7.7.6 Threat of Substitutes

7.8 Market Breakup by Segment

7.8.1 Japan Oral Antidiabetics Market
7.8.1.1 Historical Market Trends
7.8.1.2 Market Breakup by Class
7.8.1.3 Market Shares of Key Players
7.8.1.4 Market Forecast
7.8.2 Japan Insulin Market
7.8.2.1 Historical Market Trends
7.8.2.2 Market Breakup by Class
7.8.2.3 Market Shares of Key Players
7.8.2.4 Market Forecast

8 Competitive Landscape

8.1 Market Structure
8.2 Profiles of Key Players

8.2.1. B. Braun Melsungen AG
8.2.2. Eli Lilly and Company
8.2.3. Terumo Corporation
8.2.4. Becton, Dickinson (BD)
8.2.5. Novo Nordisk
8.2.6. Ypsomed AG
8.2.7. Medtronic
8.2.8. Insulet Corporation
8.2.9. Abbott Laboratories
8.2.10. DarioHealth Crop
8.2.11. Dexcom, Inc
8.2.12. Roche Diagnostic
8.2.13. Tandem Diabetes Care